News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
NCPA: More Than 125 Groups Urge Congress to Pass PBM Reform
In a letter to Congress, the National Community Pharmacists Association (NCPA) addressed the need to pass the PBM Reform Act (H.R. 4317) and 2 companion bills: the Protecting Pharmacies in Medicaid Act (S. 927) and the Patients Before Middlemen Act (S. 882).
AMA supports PBM reform in annual meeting
In the annual meeting of its House of Delegates, which concluded on June 11, the American Medical Association adopted a resolution opposing PBM spread pricing practices, including supporting state and federal legislation
Our stance on Trump’s drug pricing executive order
The National Community Pharmacists Association released their stance on Trump’s “Most Favorable Pricing” Executive Order, signed on Monday, May 12th.
NCPA Joins Class Action Suit Against GoodRx; CVS Caremark Corp.; Express Scripts, Inc.; MedImpact Healthcare Systems, Inc.; and Navitus Health Solutions, LLC
Says the discount card company is colluding with the named PBMs to fix reimbursements
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.